Nicotine receptor partial agonists for smoking cessation
<p><strong>Background</strong><br> Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonis...
Κύριοι συγγραφείς: | Livingstone-Banks, J, Fanshawe, TR, Thomas, KH, Theodoulou, A, Hajizadeh, A, Hartman, L, Lindson, N |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Cochrane Collaboration
2023
|
Παρόμοια τεκμήρια
-
Nicotine receptor partial agonists for smoking cessation
ανά: Livingstone-Banks, J, κ.ά.
Έκδοση: (2023) -
Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, C, κ.ά.
Έκδοση: (2016) -
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
ανά: Theodoulou, A, κ.ά.
Έκδοση: (2023) -
Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2011) -
Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)